Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs ProPhase Labs, Inc. (PRPH)

Advanced Biomed Inc. and ProPhase Labs, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $3.1M against $1.2M — 2.7× the size. ProPhase Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −717.4%) and the higher return on invested capital (−33.4% vs −387.3%). Across the 12 metrics below, Advanced Biomed Inc. leads on 10 and ProPhase Labs, Inc. on 2.

Valuation

Metric ADVB PRPH Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m 0.04 4.24
P/B 0.20 n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales n/m 1.84 5.18
Earnings yield 300.76% (25,845.00%) (1.50%)
Free cash flow yield (185.35%) (3,945.49%) 0.00%

Profitability

Metric ADVB PRPH Diagnostics & Research median
Gross margin — 16.38% 48.32%
Operating margin 0.00% (498.73%) (5.68%)
Net margin 0.00% (717.43%) (4.10%)
Free cash flow margin 0.00% (175.22%) 0.00%
Return on equity 84.77% (543.95%) 0.00%
Return on assets 36.47% (45.53%) (6.05%)
Return on invested capital (33.43%) (387.30%) 0.00%

Growth

Metric ADVB PRPH Diagnostics & Research median
Revenue growth (TTM) — (43.52%) 8.99%
EPS growth (last fiscal year) 266.56% 93.33% 20.36%
Revenue growth, 5-year CAGR — (21.43%) 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB PRPH Diagnostics & Research median
Debt to equity 0.00 (1.82) 0.01
Current ratio 9.33 0.05 2.27
Net debt to EBITDA 0.06 (0.74) 0.68

Dividend

Metric ADVB PRPH Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB PRPH Diagnostics & Research median
Market cap 3.14m 1.17m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack